Clinical Trial Results:
Estudio de fase IV, multicéntrico, aleatorizado y doble ciego para comparar la seguridad y eficacia de 180 µg de Pegasys® más 1000 ó 1200 mg de Copegus® con la combinación actualmente aprobada de 180 µg de Pegasys® más 800 mg de Copegus® en pacientes con infección por el virus de la hepatitis C crónica del genotipo 1 coinfectados con el virus de la inmunodeficiencia humana (VIH-1), que no hayan sido previamente tratados con interferón.
Summary
|
|
EudraCT number |
2005-005506-23 |
Trial protocol |
ES PT |
Global completion date |
30 Apr 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
04 Feb 2016
|
First version publication date |
04 Feb 2016
|
Other versions |
|
Summary report(s) |
CTg Receipt NV18209 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.